APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Model for Testing

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

In our report, all the animals used in scientific purposes are included.

Selected research

Market Outlook & Growth Opportunities

Global Animal Model for Testing Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchAnimal Model for Testing Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Model for Testing Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Animal Model for Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Model for Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Model for Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.

Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.

In our report, all the animals used in scientific purposes are included.

Read the full market overview

Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent.

In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.

This report provides an overview of the global Animal Model for Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Model for Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Model for Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Animal Model for Testing market.

Animal Model for Testing Segment by Company

Charles River Laboratories

Envigo

Taconic Biosciences

Jackson Laboratory

Crown Biosciences

Shanghai SLAC

Shangghai Modelorg

GenOway

Syngene International

Psychogenics

Pharmaron

Pharmalegacy

Vitalstar Biotechnology

Animal Model for Testing Segment by Type

Rats

Mice

Others

Animal Model for Testing Segment by Application

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Animal Model for Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal Model for Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Animal Model for Testing key companies, revenue, market share, and recent developments.

3. To split the Animal Model for Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Animal Model for Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Model for Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Model for Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Model for Testing industry.

Chapter 3: Detailed analysis of Animal Model for Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Animal Model for Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Animal Model for Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Model for Testing Industry Trends Table 2. Animal Model for Testing Industry Drivers Table 3. Animal Model for Testing Industry Opportunities and Challenges Table 4. Animal Model for Testing Industry Restraints Table 5. Global Animal Model for Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Model for Testing Revenue Share by Company (2021-2026) Table 7. Global Animal Model for Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Animal Model for Testing Key Company Manufacturing Base & Headquarters Table 9. Global Animal Model for Testing Company, Product Type & Application Table 10. Global Animal Model for Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Animal Model for Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Rats Table 15. Significant Companies of Mice Table 16. Significant Companies of Others Table 17. Global Animal Model for Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Animal Model for Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Animal Model for Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Animal Model for Testing Sales Value Share by Type (2021-2026) Table 21. Global Animal Model for Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic and Research Institutes Table 23. Significant Companies of Pharmaceutical and Biotechnology Companies Table 24. Global Animal Model for Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Animal Model for Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Animal Model for Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Animal Model for Testing Sales Value Share by Application (2021-2026) Table 28. Global Animal Model for Testing Sales Value Share by Application (2027-2032) Table 29. Global Animal Model for Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Animal Model for Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Animal Model for Testing Sales Value Share by Region (2021-2026) Table 32. Global Animal Model for Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Animal Model for Testing Sales Value Share by Region (2027-2032) Table 34. Global Animal Model for Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Animal Model for Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Animal Model for Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Animal Model for Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Animal Model for Testing Sales Value Market Share by Country (2027-2032) Table 39. Charles River Laboratories Company Information Table 40. Charles River Laboratories Business Overview Table 41. Charles River Laboratories Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Charles River Laboratories Animal Model for Testing Product Portfolio Table 43. Charles River Laboratories Recent Development Table 44. Envigo Company Information Table 45. Envigo Business Overview Table 46. Envigo Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Envigo Animal Model for Testing Product Portfolio Table 48. Envigo Recent Development Table 49. Taconic Biosciences Company Information Table 50. Taconic Biosciences Business Overview Table 51. Taconic Biosciences Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Taconic Biosciences Animal Model for Testing Product Portfolio Table 53. Taconic Biosciences Recent Development Table 54. Jackson Laboratory Company Information Table 55. Jackson Laboratory Business Overview Table 56. Jackson Laboratory Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Jackson Laboratory Animal Model for Testing Product Portfolio Table 58. Jackson Laboratory Recent Development Table 59. Crown Biosciences Company Information Table 60. Crown Biosciences Business Overview Table 61. Crown Biosciences Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Crown Biosciences Animal Model for Testing Product Portfolio Table 63. Crown Biosciences Recent Development Table 64. Shanghai SLAC Company Information Table 65. Shanghai SLAC Business Overview Table 66. Shanghai SLAC Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shanghai SLAC Animal Model for Testing Product Portfolio Table 68. Shanghai SLAC Recent Development Table 69. Shangghai Modelorg Company Information Table 70. Shangghai Modelorg Business Overview Table 71. Shangghai Modelorg Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Shangghai Modelorg Animal Model for Testing Product Portfolio Table 73. Shangghai Modelorg Recent Development Table 74. GenOway Company Information Table 75. GenOway Business Overview Table 76. GenOway Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. GenOway Animal Model for Testing Product Portfolio Table 78. GenOway Recent Development Table 79. Syngene International Company Information Table 80. Syngene International Business Overview Table 81. Syngene International Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Syngene International Animal Model for Testing Product Portfolio Table 83. Syngene International Recent Development Table 84. Psychogenics Company Information Table 85. Psychogenics Business Overview Table 86. Psychogenics Animal Model for Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Psychogenics Animal Model for Testing Product Portfolio Table 88. Psychogenics Recent Development Table 89. Pharmaron Company Information Table 90. Pharmaron Business Overview Table 91. Pharmaron Animal Model for Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pharmaron Animal Model for Testing Product Portfolio Table 93. Pharmaron Recent Development Table 94. Pharmalegacy Company Information Table 95. Pharmalegacy Business Overview Table 96. Pharmalegacy Animal Model for Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Pharmalegacy Animal Model for Testing Product Portfolio Table 98. Pharmalegacy Recent Development Table 99. Vitalstar Biotechnology Company Information Table 100. Vitalstar Biotechnology Business Overview Table 101. Vitalstar Biotechnology Animal Model for Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Vitalstar Biotechnology Animal Model for Testing Product Portfolio Table 103. Vitalstar Biotechnology Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Animal Model for Testing Product Image Figure 2. Global Animal Model for Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Model for Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Model for Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Rats Image Figure 8. Mice Image Figure 9. Others Image Figure 10. Global Animal Model for Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Animal Model for Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Animal Model for Testing Sales Value Share by Type (2021-2032) Figure 13. Academic and Research Institutes Image Figure 14. Pharmaceutical and Biotechnology Companies Image Figure 15. Global Animal Model for Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Animal Model for Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Animal Model for Testing Sales Value Share by Application (2021-2032) Figure 18. Global Animal Model for Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Animal Model for Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Animal Model for Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Animal Model for Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Animal Model for Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Animal Model for Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Animal Model for Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Animal Model for Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Animal Model for Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Animal Model for Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Animal Model for Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Animal Model for Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Animal Model for Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Animal Model for Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Animal Model for Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Rats
  • Mice
  • Others
Applications
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • Charles River Laboratories
  • Envigo
  • Taconic Biosciences
  • Jackson Laboratory
  • Crown Biosciences
  • Shanghai SLAC
  • Shangghai Modelorg
  • GenOway
  • Syngene International
  • Psychogenics
  • Pharmaron
  • Pharmalegacy
  • Vitalstar Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Model for Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Model for Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Animal Model for Testing Market Dynamics
  1. 2.1 Animal Model for Testing Industry Trends
  2. 2.2 Animal Model for Testing Industry Drivers
  3. 2.3 Animal Model for Testing Industry Opportunities and Challenges
  4. 2.4 Animal Model for Testing Industry Restraints
3 Animal Model for Testing Market by Company
  1. 3.1 Global Animal Model for Testing Company Revenue Ranking in 2025
  2. 3.2 Global Animal Model for Testing Revenue by Company (2021-2026)
  3. 3.3 Global Animal Model for Testing Company Ranking (2024-2026)
  4. 3.4 Global Animal Model for Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Animal Model for Testing Company Product Type and Application
  6. 3.6 Global Animal Model for Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Animal Model for Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Animal Model for Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Animal Model for Testing Market by Type
  1. 4.1 Animal Model for Testing Type Introduction
  2. 4.1.1 Rats
  3. 4.1.2 Mice
  4. 4.1.3 Others
  5. 4.2 Global Animal Model for Testing Sales Value by Type
  6. 4.2.1 Global Animal Model for Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Animal Model for Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Animal Model for Testing Sales Value Share by Type (2021-2032)
5 Animal Model for Testing Market by Application
  1. 5.1 Animal Model for Testing Application Introduction
  2. 5.1.1 Academic and Research Institutes
  3. 5.1.2 Pharmaceutical and Biotechnology Companies
  4. 5.2 Global Animal Model for Testing Sales Value by Application
  5. 5.2.1 Global Animal Model for Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Animal Model for Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Animal Model for Testing Sales Value Share by Application (2021-2032)
6 Animal Model for Testing Regional Value Analysis
  1. 6.1 Global Animal Model for Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Model for Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Animal Model for Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Animal Model for Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Model for Testing Sales Value (2021-2032)
  7. 6.3.2 North America Animal Model for Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Animal Model for Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Animal Model for Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Animal Model for Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Animal Model for Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Animal Model for Testing Sales Value (2021-2032)
  16. 6.6.2 South America Animal Model for Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Animal Model for Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Animal Model for Testing Sales Value Share by Country, 2025 VS 2032
7 Animal Model for Testing Country-level Value Analysis
  1. 7.1 Global Animal Model for Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Model for Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Animal Model for Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Animal Model for Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Animal Model for Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Animal Model for Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Animal Model for Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Animal Model for Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Animal Model for Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Animal Model for Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Animal Model for Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Animal Model for Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Animal Model for Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Animal Model for Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Animal Model for Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Animal Model for Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Animal Model for Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Animal Model for Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Animal Model for Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Animal Model for Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Animal Model for Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Animal Model for Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Animal Model for Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Animal Model for Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Animal Model for Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Animal Model for Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Animal Model for Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Animal Model for Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Animal Model for Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Animal Model for Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Animal Model for Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Animal Model for Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Animal Model for Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Animal Model for Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River Laboratories
  2. 8.1.1 Charles River Laboratories Company Information
  3. 8.1.2 Charles River Laboratories Business Overview
  4. 8.1.3 Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
  6. 8.1.5 Charles River Laboratories Recent Developments
  7. 8.2 Envigo
  8. 8.2.1 Envigo Company Information
  9. 8.2.2 Envigo Business Overview
  10. 8.2.3 Envigo Animal Model for Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Envigo Animal Model for Testing Product Portfolio
  12. 8.2.5 Envigo Recent Developments
  13. 8.3 Taconic Biosciences
  14. 8.3.1 Taconic Biosciences Company Information
  15. 8.3.2 Taconic Biosciences Business Overview
  16. 8.3.3 Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
  18. 8.3.5 Taconic Biosciences Recent Developments
  19. 8.4 Jackson Laboratory
  20. 8.4.1 Jackson Laboratory Company Information
  21. 8.4.2 Jackson Laboratory Business Overview
  22. 8.4.3 Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
  24. 8.4.5 Jackson Laboratory Recent Developments
  25. 8.5 Crown Biosciences
  26. 8.5.1 Crown Biosciences Company Information
  27. 8.5.2 Crown Biosciences Business Overview
  28. 8.5.3 Crown Biosciences Animal Model for Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
  30. 8.5.5 Crown Biosciences Recent Developments
  31. 8.6 Shanghai SLAC
  32. 8.6.1 Shanghai SLAC Company Information
  33. 8.6.2 Shanghai SLAC Business Overview
  34. 8.6.3 Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
  36. 8.6.5 Shanghai SLAC Recent Developments
  37. 8.7 Shangghai Modelorg
  38. 8.7.1 Shangghai Modelorg Company Information
  39. 8.7.2 Shangghai Modelorg Business Overview
  40. 8.7.3 Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
  42. 8.7.5 Shangghai Modelorg Recent Developments
  43. 8.8 GenOway
  44. 8.8.1 GenOway Company Information
  45. 8.8.2 GenOway Business Overview
  46. 8.8.3 GenOway Animal Model for Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GenOway Animal Model for Testing Product Portfolio
  48. 8.8.5 GenOway Recent Developments
  49. 8.9 Syngene International
  50. 8.9.1 Syngene International Company Information
  51. 8.9.2 Syngene International Business Overview
  52. 8.9.3 Syngene International Animal Model for Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Syngene International Animal Model for Testing Product Portfolio
  54. 8.9.5 Syngene International Recent Developments
  55. 8.10 Psychogenics
  56. 8.10.1 Psychogenics Company Information
  57. 8.10.2 Psychogenics Business Overview
  58. 8.10.3 Psychogenics Animal Model for Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Psychogenics Animal Model for Testing Product Portfolio
  60. 8.10.5 Psychogenics Recent Developments
  61. 8.11 Pharmaron
  62. 8.11.1 Pharmaron Company Information
  63. 8.11.2 Pharmaron Business Overview
  64. 8.11.3 Pharmaron Animal Model for Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmaron Animal Model for Testing Product Portfolio
  66. 8.11.5 Pharmaron Recent Developments
  67. 8.12 Pharmalegacy
  68. 8.12.1 Pharmalegacy Company Information
  69. 8.12.2 Pharmalegacy Business Overview
  70. 8.12.3 Pharmalegacy Animal Model for Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
  72. 8.12.5 Pharmalegacy Recent Developments
  73. 8.13 Vitalstar Biotechnology
  74. 8.13.1 Vitalstar Biotechnology Company Information
  75. 8.13.2 Vitalstar Biotechnology Business Overview
  76. 8.13.3 Vitalstar Biotechnology Animal Model for Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
  78. 8.13.5 Vitalstar Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst